TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 12 filers reported holding TRANSCODE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,196 | – | 30,120 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,270,600 | $3,228,000 | 0.98% |
| Worth Venture Partners, LLC | 295,540 | $751,000 | 0.37% |
| ACT CAPITAL MANAGEMENT, LLC | 50,000 | $127,000 | 0.09% |
| Kepos Capital LP | 300,000 | $762,000 | 0.06% |
| Redmond Asset Management, LLC | 88,010 | $224,000 | 0.06% |
| K.J. Harrison & Partners Inc | 16,000 | $41,000 | 0.01% |
| Shay Capital LLC | 15,060 | $38,000 | 0.01% |
| High Net Worth Advisory Group LLC | 2,500 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 71,272 | $181,000 | 0.00% |